MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-24-2026
Neoleukin Therapeutics P/E Ratio 2011-2026 | NLTX
Annual P/E Ratio Neoleukin Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 0.126 | -0.68 | -2.34 | -20.5 | -4.58 | -1.67 | -6.07 | -9 | -6.06 | -3.83 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.126 | -20.5 | -5.46 |
P/E Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
-1.71 | - | 7.5 % | $ 6.35 M |  USA |
 |
Assertio Holdings
ASRT
|
-2.48 | $ 18.43 | -0.91 % | $ 118 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.679 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-4.35 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
-10.4 | - | - | $ 11.5 B | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-46.5 | $ 3.16 | 2.93 % | $ 44.4 M | USA |
 |
DURECT Corporation
DRRX
|
-1.15 | - | - | $ 50.1 M | USA |
 |
Endo International plc
ENDP
|
-0.0278 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.287 | - | - | $ 36.6 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.0895 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-5.04 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
-0.111 | - | -23.39 % | $ 1.76 M | USA |
 |
Cronos Group
CRON
|
-49.6 | $ 2.56 | 1.39 % | $ 1.33 B |  Canada |
 |
Harrow Health
HROW
|
-376 | $ 36.3 | 2.46 % | $ 1.33 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-14.7 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
-0.0479 | - | - | $ 33.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-1.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-0.775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
-5.71 | $ 5.35 | 1.62 % | $ 1.95 B | Canada |
 |
Aurora Cannabis
ACB
|
-1.32 | $ 3.41 | 1.19 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-0.237 | $ 1.02 | 2.62 % | $ 110 M | Canada |
 |
Organogenesis Holdings
ORGO
|
482 | $ 2.45 | 8.38 % | $ 323 M | USA |
 |
PetIQ
PETQ
|
186 | - | 1.64 % | $ 400 M | USA |
 |
Pacira BioSciences
PCRX
|
-11.8 | $ 22.98 | 1.98 % | $ 1.06 B | USA |
 |
ProPhase Labs
PRPH
|
7.07 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-5.38 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-10 | - | -4.76 % | $ 65.3 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
9.54 | - | -39.89 % | $ 27.7 M | USA |
 |
Evolus
EOLS
|
-5.26 | $ 4.12 | 0.86 % | $ 266 M | USA |
 |
OrganiGram Holdings
OGI
|
-2.92 | $ 1.4 | 2.18 % | $ 402 M | Canada |
 |
Emergent BioSolutions
EBS
|
-0.182 | $ 8.32 | 5.99 % | $ 426 M | USA |
 |
Sundial Growers
SNDL
|
-0.00386 | $ 1.37 | 4.58 % | $ 3.37 M | Canada |
 |
Solid Biosciences
SLDB
|
-3.57 | $ 7.95 | 2.71 % | $ 696 M | USA |
 |
Lannett Company
LCI
|
-0.108 | - | 1.15 % | $ 7.11 M | USA |
 |
Tilray
TLRY
|
-0.821 | $ 6.72 | 4.02 % | $ 4.15 B | Canada |
 |
Veru
VERU
|
-2.85 | $ 2.54 | 2.42 % | $ 343 M | USA |
 |
Viatris
VTRS
|
336 | $ 13.57 | 3.08 % | $ 16.3 B | USA |
 |
OptiNose
OPTN
|
-5.4 | - | - | $ 1.08 B | USA |
 |
cbdMD
YCBD
|
-11 | $ 0.72 | 0.35 % | $ 3.11 M | USA |
 |
PLx Pharma
PLXP
|
-2.56 | - | -27.8 % | $ 2.56 M | USA |
 |
Relmada Therapeutics
RLMD
|
-4.3 | $ 6.93 | 2.67 % | $ 274 M | USA |
 |
Rockwell Medical
RMTI
|
-6.36 | $ 0.93 | -1.77 % | $ 33.5 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-1.06 | $ 2.27 | 2.49 % | $ 2.82 M | USA |
 |
SCYNEXIS
SCYX
|
-4.41 | $ 0.97 | 1.13 % | $ 48.4 M | USA |
 |
Zomedica Corp.
ZOM
|
-3.97 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.536 | - | - | $ 55.5 M | USA |
 |
Tricida
TCDA
|
-2.03 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-0.862 | $ 0.61 | -1.16 % | $ 2.62 M |  China |
 |
TherapeuticsMD
TXMD
|
-40.5 | $ 2.13 | 5.69 % | $ 24.6 M | USA |